RankAlpha logo
Back to Rankings

TVRD

Tvardi TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
TVRD vs peer average
66/100
TVRD vs. peer average (C vs. D)
Grade spread
C 3 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BIVI is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $11.35M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBIVIBioVie
TVRD
Tvardi Therapeutics
BIVI
BioVie
Grade
C
F
Momentum
7
7
Value
58
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs BIVI

TVRD / BIVI
Grade Position
In line
TVRD vs. peer average (C vs. D)
66/100
Momentum
7
TVRD
Value
58
TVRD
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TVRD
1
BIVI
BioVie Inc Class A Common
F
20/100
-2
2
CLRB
Cellectar Biosciences Inc Common
C
60/100
Even
3
ASBP
Aspire-Lakewood Holdings Inc Common
D
40/100
-1
4
LSTA
Lisata Therapeutics Inc Common
D
40/100
-1
5
GDTC
CytoMed Therapeutics Ltd Common
C
60/100
Even
BIVI is the first peer returned for this comparison set.